LE, C., N, M., S, J., R, O., & O, H. (2025). Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(10), e70763. https://doi.org/10.1002/alz.70763
Chicago Style (17th ed.) CitationLE, Collij, Mattsson-Carlgren N, Janelidze S, Ossenkoppele R, and Hansson O. "Complementary Utility of Plasma Biomarkers and Aβ-PET for Diagnosis, Risk-stratification, and Treatment Monitoring in Alzheimer's Disease." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 21, no. 10 (2025): e70763. https://doi.org/10.1002/alz.70763.
MLA (9th ed.) CitationLE, Collij, et al. "Complementary Utility of Plasma Biomarkers and Aβ-PET for Diagnosis, Risk-stratification, and Treatment Monitoring in Alzheimer's Disease." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 21, no. 10, 2025, p. e70763, https://doi.org/10.1002/alz.70763.
